Answers are grounded in this paper and cite their sources.
Introduction: Thyroid peroxidase autoantibodies are a very important diagnostic parameter. They are mainly found in patients with autoimmune thyroid diseases (Hashimoto's thyroiditis, spontaneous hypothyroidism, Bazedov's disease). Objective: Analysis of the results of the method we use in clinical practice. Material and working methods: Autoantibodies to thyrocytic peroxidase were determined using the Monobind method, USA. So far we have made over 2000 determinations. The method consists of a chemiluminescent immunoassay, using thyroid peroxidase labeled with biotin and plastic tubes coated with streptavidin. Calibration was done with international standard 66/387 for thyroid microsomes. Results: In the last 8 years, we have done over 2000 determinations with hundreds of people. In about fifty of them the examined parameter was done as a "follow-up" study. Conclusion: We presented the results of determination of antibodies to thyrocytic peroxidase. The method we used gives very reliable results. During the "follow-up" study, the results were sometimes not constant in the same subject.
No takes yet. Share an insight, caveat, or question.
Paunković et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: